Adequate Insertion Depth of Dilator During Central Venous Catheterization

Central Venous Catheterization Clinical Trial

Official title:

Adequate Insertion Depth of Dilator During Central Venous Catheterization Through the Right Internal Jugular Vein

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04279808
• Other study ID #: 10-2019-3
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 2020
• Est. completion date: January 2021

Study information

• Verified date: February 2020
• Source: Seoul National University Hospital
• Contact: Jung-Man Lee, M.D.,PhD.
• Phone: +82-2-870-2513
• Email: jungman007[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

For safe central catheterization, clinicians must be aware of adequate dilator insertion depth not to directly dilate the venous wall. The purpose of the study is to find out adequate insertion depth of the dilator during central venous catheterization through the internal jugular vein with the aid of real-time ultrasonography.

Description:

This randomized controlled trial is to compare the distance between the skin puncture site and the outside of anterior wall of the internal jugular vein measured by real-time ultrasonography with the conventional method which is routinely used in common clinical practice.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 68
• Est. completion date: January 2021
• Est. primary completion date: January 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• adult patients requiring central venous catheterization through the right internal jugular vein

Exclusion Criteria:

• suspicion for infection of the right neck site

Related Conditions & MeSH terms

• Central Venous Catheterization

Intervention

Procedure:
• dilator depth
For soft tissue dilation just after guidewire insertion in central venous catheterization through the right internal jugular vein, investigators will measure the distance between the skin puncture site and outside of anterior wall of the vein with real-time ultrasonography in the measured depth group. Next, practitioner will insert the dilator by the measured length and continue to insert the central venous catheter. For the conventional group as a control group, practitioner will perform the central venous catheterization with a manner used routinely by the practitioner.

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Seoul National University Hospital	SMG-SNU Boramae Medical Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	hematoma realted with the dilator	hematoma from the vascular wall puncture by the dilator	1 Day (on the study day for each patient)
Secondary	distance between skin puncture site and the outside of the anterior wall of the internal jugular vein	distance between skin puncture site and the outside of the anterior wall of the internal jugular vein which will be measured by real-time ultrasonography	1 Day (on the study day for each patient)